Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Artiva Biotherapeutics Statistics
Total Valuation
Market Cap | n/a |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | 6.16 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 12.98 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $404,370 |
Profits Per Employee | -$320,568 |
Employee Count | 81 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ARTV has paid $72,000 in taxes.
Income Tax | 72,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ARTV had revenue of $32.75 million and -$25.97 million in losses.
Revenue | 32.75M |
Gross Profit | 32.75M |
Operating Income | -27.48M |
Pretax Income | -25.89M |
Net Income | -25.97M |
EBITDA | -25.78M |
EBIT | -28.06M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $62.13 million in cash and $16.26 million in debt, giving a net cash position of $45.88 million.
Cash & Cash Equivalents | 62.13M |
Total Debt | 16.26M |
Net Cash | 45.88M |
Net Cash Per Share | n/a |
Equity (Book Value) | -174.67M |
Book Value Per Share | n/a |
Working Capital | 55.52M |
Cash Flow
In the last 12 months, operating cash flow was -$48.27 million and capital expenditures -$1.41 million, giving a free cash flow of -$49.69 million.
Operating Cash Flow | -48.27M |
Capital Expenditures | -1.41M |
Free Cash Flow | -49.69M |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -83.88% and -79.28%.
Gross Margin | 100.00% |
Operating Margin | -83.88% |
Pretax Margin | -79.06% |
Profit Margin | -79.28% |
EBITDA Margin | -78.71% |
EBIT Margin | -85.65% |
FCF Margin | -151.70% |
Dividends & Yields
ARTV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |